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Objectives. To evaluate the performances of six different bone substitute materials used as graft in maxillary sinus augmentation
by means of histological and histomorphometric analysis of bone biopsies retrieved from human subjects after a 6-month healing
period. Materials and Methods. Six consecutive patients (3 males, 3 females, aged 50-72 years), healthy, nonsmokers, and with
good oral hygiene, presenting edentulous posterior maxilla with a residual bone crest measuring ≤ 4 mm in vertical height
and 3 to 5 mm in horizontal thickness at radiographic examination, were selected to receive sinus augmentation and delayed
implant placement. Under randomized conditions, sinus augmentation procedures were carried out using mineralized solvent-
dehydrated bone allograft (MCBA), freeze-driedmineralized bone allograft (FDBA), anorganic bovine bone (ABB), equine-derived
bone (EB), synthetic micro-macroporous biphasic calcium-phosphate block consisting of 70% beta-tricalcium phosphate and 30%
hydroxyapatite (HA-𝛽-TCP 30/70), or bioapatite-collagen (BC). After 6 months, bone core biopsies were retrieved and 13 implants
were placed. Bone samples were processed for histological and histomorphometric analysis. CT scans were taken before and
after surgery. After 4 months of healing, patients were restored with a provisional fixed acrylic resin prosthesis, as well as after
further 2-4 months with a definitive cemented zirconia or porcelain-fused-to-metal crowns. Results. There were no postoperative
complications or implant failures. The histological examination showed that all biomaterials were in close contact with newly
formed bone, surrounding the graft granules with a bridge-like network. No signs of acute inflammation were observed. The
histomorphometry revealed 20.1% newly formed bone for MCBA, 32.1% for FDBA, 16.1% for ABB, 22.8% for EB, 20.3% for HA-𝛽-
TCP 30/70, and 21.4% for BC. Conclusions. Within the limitations of the present investigation, all the six tested biomaterials showed
good biocompatibility and osteoconductive properties when used in sinus augmentation procedures, although the FDBA seemed
to have a better histomorphometric result in terms of newly formed bone and residual graft material. This trial is registered with
ClinicalTrials.gov Identifier (Registration Number): NCT03496688.
1. Introduction
The lack of adequate bone height and thickness negatively
affects implant-supported rehabilitation in the edentulous
posterior maxilla. Therefore, bone-grafting procedures are
needed to increase the available bone volume and to provide
structural and mechanical support for the placement of
dental implants.
Among graft materials, autologous bone is considered
the gold standard due to its osteogenic, osteoinductive,
and osteoconductive properties [1–3]. However, the use of
autogenous bone has significant drawbacks such as a limited
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Table 1: Patient characteristics at study baseline.
N Sex Age Implant location Type of implant
Length Diameter
1 M 72 1.4 10 3.75
1.6 11.5 5
2 F 62 2.6 10 5
2.7 10 5
3 F 54 1.4 13 5.5
1.6 13 5.5
4 F 50 2.4 10 4.3
2.6 13 5.5
5 M 57 1.3 13 4
1.5 10 4
1.7 11.5 5
6 M 63 2.4 13 4
2.6 10 5
intraoral supply, the need of general anesthesia in case of
extraoral harvesting, donor site morbidity, increased oper-
ating time, need of two surgical sites, tendency to partial
resorption and potential intraoperative, and postoperative
complications [2, 4–7].
To overcome these disadvantages, a large number of bio-
materials have been used alone or in combination with auto-
grafts in augmentation procedures [8–19]. Among the osteo-
conductive materials, allografts (fresh-frozen bone, freeze-
dried bone, demineralized freeze-dried bone), xenografts (of
bovine, equine, or porcine origin), and alloplastic materi-
als (different combination of calcium-phosphate, bioactive
glasses, polymers) were described in the dental literature
as being able to enhance bone formation. Furthermore,
several studies have shown that the biomaterials may not
adversely influence clinical outcomes and implant survival
when compared to autogenous bone [20, 21].
The two-stage sinus lift augmentation with delayed
implant insertion was considered a good clinical model to
evaluate the performance of graft materials, because bone
formation occurs within an enclosed space and with a
minimal interference from external factors. In addition, this
procedure is highly predictable and allows collecting bone
biopsy specimens during implant insertion avoiding any
additional discomfort for the patients [17, 20].
The aim of the present study was to evaluate the perfor-
mances of six different bone substitute materials used as graft
inmaxillary sinus augmentation, bymeans of histological and
histomorphometric analysis of bone biopsies retrieved from
human subjects after a healing period of 6 months.
2. Materials and Methods
2.1. Patient Selection. Six patients (3 males, 3 females, aged
50–72 years) who were healthy, nonsmokers, and with
good oral hygiene were recruited in this study among
those referred to Department of Oral and Maxillofacial Sci-
ences, Sapienza University of Rome, for implant-supported
rehabilitation in the posterior atrophic maxilla (Table 1).
Inclusion criteria were maxillary partial edentulism in the
premolar/molar areas, with a residual bone crest measuring
≤ 4 mm in vertical height and 3 to 5 mm in horizontal
thickness as measured on computerized tomography (CT)
scan. Exclusion criteria were being pregnant or lactating
females, patients with impaired systemic conditions, smoking
habit, andmaxillary sinus pathology. After clinical and radio-
graphic evaluation, the patients signed a written informed
consent form to study participation.
All the clinical procedures were performed in accordance
with the Declaration of Helsinki and the Good Clinical
Practice Guidelines. The protocol of the study was approved
by the Ethical Committee of the Sapienza University of Rome
(n. 3447).
2.2. Surgical and Restorative Procedures. The preoperative
antibiotic and analgesic therapy with Amoxicillin 875 mg
+ Clavulanic acid 125 mg (Augmentin, GlaxoSmithKline,
Belgium) and Ketoprofene 200 mg (Ibifen, 200 mg, IBI
Lorenzini, Aprilia, Italy) was given orally 1 hour prior to
surgery. Immediately prior to surgery, patients rinsed with
a chlorhexidine digluconate solution 0.2% (Corsodyl, Glaxo-
SmithKline, Belgium) for 2 min, to be continued for 2 weeks
postoperatively.
Surgery was performed under sterile conditions and
local anesthesia (mepivacaine 2%with epinephrine 1:100.000,
Carbocaine, AstraZeneca, Italy). A lateral window technique
was used for sinus floor elevation. A slightly palatal crestal
incision and two vertical releasing incisionsweremademesial
and distal on the buccal mucosa according to the sinus
anatomy to elevate a mucoperiosteal flap (Figure 1(a)). On
the lateral side of the sinus wall, the oval-shaped bony
window was performed, with the inferior border about 5
mm from the alveolar crest and the superior portion left
intact, to create a trapdoor effect (Figure 1(b)). The sinus
membrane was carefully raised and, together with the bony
window, was rotated inward and upward (Figure 1(c)). The




Figure 1: Intraoperative views of the sinus augmentation procedure: (a) mobilization of the mucoperiosteal flap; (b) oval-shaped bony
window; (c) sinus membrane elevation; (d) graft material in place; (e) resorbable membrane over the lateral window; (f) suture; (g) bone
core biopsy and implant placement; (h) trephine bur and harvested specimen; (i) suture.
subantral cavity was packed with the graft material (Fig-
ure 1(d)) and a resorbable membrane (Bio-Gide, Geistlich
Biomaterials Italy S.r.l.) was placed over the lateral wall
defect (Figure 1(e)). The mucoperiosteal flap was replaced
and stabilizedwith resorbable interrupted sutures (5-0Vicryl,
Johnson & Johnson Medical, Norderstedt, Germany), which
were removed after 2 weeks (Figure 1(f)). Postoperatively,
the antibiotic therapy was prescribed for 1 week (Amoxicillin
875 mg + Clavulanic acid 125 mg twice a day) and, if neces-
sary, the analgesic therapy was continued with Ketoprofene
200 mg.
After 6 months clinical and radiographic examinations
were performed and each patient was reappointed for biopsy
and implant placement in the same location. Under local
anesthesia, a full thickness flap was raised and a bone biopsy
was performed using a 3.5 mm trephine bur under sterile
saline solution irrigation, guided by the radiographic/surgical
template in the selected implant site. A total of six bone sam-
ples were retrieved from the occlusal aspect of the alveolar
crest, one from each augmented site and at least two implants
(NobelParallel CC or NobelSpeedy, Nobel Biocare Italiana
S.r.l., Italy), were placed according to the manufacturer’s
indications (Figures 1(g), 1(h), and 1(i)).
To identify crestal bone during histologic and histomor-
phometric procedures, the harvested specimens weremarked
with toluidine blue stain on the occlusal side.
After 4 months of healing, patients were provisionally
restored with a fixed acrylic resin prosthesis and after 2 to
4 months of function, the definitive prosthetic rehabilitation
was applied with cemented zirconia or porcelain-fused-to-
metal crowns.
Under randomized conditions, each sinus augmentation
procedure was carried out using one of the following six
commercial bone substitute materials: mineralized solvent-
dehydrated bone allograft (MCBA, Puros; Zimmer Dental
GmbH, Freiburg, Germany); freeze-dried mineralized bone
allograft (FDBA, Organizzazione Toscana Trapianti, Azienda
Ospedaliero-Universitaria Careggi, Florence, Italy); anor-
ganic bovine bone (ABB, Bio-Oss, Geistlich Biomaterials
Italia S.r.l.); equine-derived bone ( EB osteOXenon- Bioteck
S.p.A., Arcugnano (VI), Italy); synthetic micro-macroporous
biphasic calcium-phosphate block consisting of 70% beta-
tricalcium phosphate and 30% hydroxyapatite (HA-𝛽-TCP
30/70, BioCer Entwicklungs GmbH, Bayreuth, Germany);
and bioapatite-collagen ( BC, Biostite, GABA Vebas San
Giuliano Milanese, MI, Italy).
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MCBA is cancellous or cortical mineralized solvent-
dehydrated bone allograft obtained from cadaveric bone
by a processing technique (Tutoplast Process, RTI Biolog-
ics, Alachua, FL), which preserves the bone architecture
maintaining its biomechanical properties and minimizing
antigenicity and infective potential [8, 9, 22].
FDBA is freeze-dried mineralized bone allograft pro-
cessed using lyophilization; it maintains both the organic and
the inorganic component (salts of calcium and phosphate),
and when used as a graft material, the mineral content
is broken down by osteoclasts, becoming osteoinductive
proteins available to induce new bone formation. However,
to release osteoinductive proteins from the FDBA organic
matrix, a prolonged osteoclast mediated demineralization is
needed [23].
ABB is a xenogenic material formed by deproteinized
sterilized bovine cancellous bone with 75% porosity and a
crystal size of about 10 𝜇m in the form of granules. Its native
crystal-line structure is chemically and physically highly
similar to human bone and its porous nature promotes the
initial biologic processes of cell adhesion and proliferation
[19]. This material is well documented and has been shown
to be well integrated into host bone tissue in different clinical
and histological results [24–26].
EB is an equine-derived bone tissue deantigenated by
a proteolytic low temperature process that preserves type 1
bone collagen and makes it anorganic although it conserves
unaltered its mineral structure of hydroxyapatite saving the
resorption potential [10, 27–29].
HA-𝛽-TCP 30/70 is a new bioceramic with reticular
structure, which seems to have a better resorption and an
increased bone formation due to the levels of released calcium
and phosphorous ions able to stimulate new bone formation
[8, 16, 30–33]. Indeed, HA seems to act as scaffold and TCP
as the resorbable component.
BC is hydroxyapatite associated with type I bovine col-
lagen plus glucosamine. Different studies showed its efficacy
as human bone substitute material in the sinus augmentation
procedure [34, 35].The presence of collagen accelerates fibrin
formation of the clot while glucosamine improves the bone
mineralization progression.
2.3. Histological Procedure. The bone cores were retrieved
and were immediately stored in 10% buffered formalin and
processed to obtain thin ground sections.The specimenswere
processed using the Precise 1 Automated System (Assing,
Rome, Italy) [35]. The specimens were dehydrated in a
graded series of ethanol rinses and embedded in a glycol
methacrylate resin (Technovit 7200 VLC, Kulzer, Wehrheim,
Germany). After polymerization, the specimens were sec-
tioned, along their longitudinal axis, with a high precision
diamond disk at about 150 𝜇 m, and ground down to about
30 𝜇m with a specially designed grinding machine Precise 1
Automated System (Assing, Rome, Italy). Three slides were
obtained from each specimen. These slides were stained
with acid fuchsin and toluidine blue and examined with
transmitted light Leitz Laborlux microscope (Leitz, Wetzlar,
Germany).
Histomorphometry of the percentages of newly formed
bone, residual grafted material, and marrow spaces was
carried out using a light microscope (Laborlux S, Leitz,
Wetzlar, Germany) connected to a high-resolution video
camera (3CCD, JVCKY-F55B, JVC, Yokohama, Japan) and
interfaced with a monitor and PC (Intel Pentium III 1200
MMX, Intel, Santa Clara, CA, USA). This optical system
was associated with a digitizing pad (Matrix Vision GmbH,
Oppenweiler, Germany) and a histometry software package
with image capturing capabilities (Image-Pro Plus 4.5, Media
Cybernetics Inc., Immagini & Computer Snc, Milan, Italy).
3. Results
3.1. Clinical Results. The healing process after sinus aug-
mentation procedures was uneventful. No postoperative
complications were present. In no case there was perforation
of the sinus membrane. No clinical sign of sinus pathology
was observed. Six months after sinus augmentation, the
radiographic evaluation of all patients showed the presence
of dense bone in themaxillary sinuses where the biomaterials
were inserted (Figure 2).
Primary stability of the implants was achieved in all cases
independently of the use of bone substitute material (inser-
tion torque value was at least 35 N ). All 13 implants placed
during the biopsy retrievement had no complications and
were osseointegrated at the end of prosthetic rehabilitation.
No failures and no dropouts occurred.
3.2. Histological andHistomorphometric Results. Mineralized
solvent-dehydrated bone (MCBA). At low magnification,
trabecular bone with large marrow spaces and biomaterial
particleswas observed (Figure 3(a)).Thebiomaterial particles
showed different sizes and they were partially surrounded by
newly formed bone. Newly formed bone was characterized
by large osteocyte lacunae and bridged up greatest part of the
biomaterial particles (Figure 3(b)). In some fields, osteoblasts
were observed in the process of apposing bone directly on the
particle surface. In themarrow spaces only few inflammatory
cells were detected. Histomorphometry showed that newly
formed bone represented 20.1%,marrow spaces 57.5% and the
residual graft material 22.4%.
Freeze-dried mineralized bone allograft (FDBA). At low
power magnification, newly formed bone with marrow
spaces and particles of residual biomaterial was present. In
a marginal portion of the sample, preexisting bone with
small remodeling areas could be observed (Figure 4(a)).
At high power magnification, in some fields, the bioma-
terial particles were completely osseointegrated and areas
of bone neoformation could be observed also inside the
particles. Some of the biomaterial particles showed irregu-
lar margins, typical of a resorption process (Figure 4(b)).
Bone neoformation areas could be seen both in contact
with the biomaterial particles and in the marrow spaces,
where few spindle cells could also be detected. Histo-
morphometry showed that newly formed bone represented
32.1%, marrow spaces 47.8%, and the residual graft material
20.1%.
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(a) (b) (c)
Figure 2: Radiographic evaluation: (a) CT scan before surgery; (b) CT scan after 6 months of graft healing; (c) CT scan after implant
placement.
(a) (b)
Figure 3: Mineralized solvent-dehydrated bone (toluidine blue and acid fuchsin): (a) trabecular bone with large marrow spaces and
biomaterial particles was observed (original magnification 12X); (b) the biomaterial particles showed different sizes and they were partially
surrounded by newly formed bone that was characterized by large osteocyte lacunae (original magnification 40X).
(a) (b)
Figure 4: Freeze-driedmineralized bone allograft (toluidine blue and acid fuchsin): (a) newly formed bone withmarrow spaces and particles
of residual biomaterial was present. In a marginal portion of the sample, preexisting bone with small remodeling areas could be observed
(original magnification 12X); (b) the biomaterial particles, showing areas of bone neoformation in their inner part, could be observed. Some
of the biomaterial particles showed irregular margins, typical of a resorption process (original magnification 40X).
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(a) (b)
Figure 5: Anorganic bovine bone (toluidine blue and acid fuchsin): (a) the specimen appeared to be constituted by two separate fragments,
where several particles of residual biomaterial were evident (original magnification 12X); (b) the areas of bone neoformation in tight contact
with the biomaterial surface were present. In some fields, new bone formation inside the biomaterial particles could be observed (original
magnification 40X).
(a) (b)
Figure 6: Equine-derived bone (toluidine blue and acid fuchsin): (a) trabecular bone with large marrow spaces and biomaterial particles
was observed. The biomaterial particles were located in the apical portion of the biopsy and they were surrounded by new bone (original
magnification 12X); (b) the bone was in close contact with the granules and in some areas osteoblasts were observed in the process of apposing
bone directly on the particle surface (original magnification 40X).
Anorganic bovine bone (ABB). At low power mag-
nification, the specimen appeared to be formed by two
separate fragments, each presenting several residual bioma-
terial particles (Figure 5(a)). At high power magnification,
most of the biomaterial particles showed areas of bone
neoformation in tight contact with the biomaterial surface
(Figure 5(b)). The newly formed bone in contact with the
biomaterial particles showed wide osteocyte lacunae, typical
of a young bone. In some fields, new bone formation
inside the biomaterial particles could be observed. Histo-
morphometry showed that newly formed bone represented
16.1%, marrow spaces 46.7% and the residual biomaterial
37.2%.
Equine-derived bone (EB). At low magnification, trabec-
ular bone with large marrow spaces and biomaterial particles
was observed (Figure 6(a)). The particles were located in the
apical portion of the biopsy and they were surrounded by
new bone. In many fields the bone was in strict contact with
the granules and in some areas osteoblasts were observed
in the process of apposing bone directly on the particle
surface (Figure 6(b)). Many large vessels could be detected.
No inflammatory cells, or multinucleated giant cells, were
present around the biomaterial or at the interface with
bone. Histomorphometry showed that newly formed bone
represented 22.8%, marrow spaces 47.1%, and the residual
graft material 30.1%.
Synthetic micro-macroporous biphasic calcium-phos-
phate (HA-𝛽-TCP 30/70). In the examined sample, newly
formed trabecular bone and preexisting bone with marrow
spaces and residual biomaterial could be observed (Fig-
ure 7(a)). At low power magnification, the residual biomate-
rial was surrounded by newly formed bone and no gaps were
present at the bone biomaterial interface. In some portions
of the specimen the graft seemed to undergo resorption
(Figure 7(b)). No inflammatory cells or multinucleated giant
cells were present around the biomaterial or at the interface
with bone. Many small and large sized vessels could be
observed. Histomorphometry showed that newly formed
bone represented 20.3%, marrow spaces 41.8%, and the
residual graft material 37.9%.
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(a) (b)
Figure 7: Synthetic micro-macroporous biphasic calcium-phosphate (HA-𝛽-TCP 30/70) (toluidine blue and acid fuchsin): (a) trabecular
bone with marrow spaces and residual biomaterial, located in the apical portion of the sample, could be observed (original magnification
12X); (b) the residual biomaterial was surrounded by newly formed bone and no gaps were present at the bone biomaterial interface. In some
fields, the graft seemed to undergo resorption. Many large blood vessels could be seen (original magnification 40X).
(a) (b)
(c)
Figure 8: Bioapatite-collagen (toluidine blue and acid fuchsin): (a) trabecular bonewithmarrow spaces and residual biomaterial particles was
observed (original magnification 12X); (b) osteoblasts were observed in the process of apposing bone directly on the particle surface. Marrow
spaces were colonized by small and large blood vessels in close proximity to the new bone and to the particles (original magnification 40X);
(c) moderate inflammatory infiltrate and multinucleated giant cells, probably osteoclasts, were observed directly on the biomaterial particles
surface (original magnification 400X).
Bioapatite-collagen (BC). In the examined sample, tra-
becular bone with marrow spaces and residual biomaterial
was observed (Figure 8(a)). Specifically, half of the sample
was formed by residual biomaterial surrounded by newly
formed bone, while in an apical portion of the sample
many particles were partially covered by connective tissue.
The new bone produced a network, “bridging” between
the particles (Figure 8(b)). In a few fields, osteoblasts were
observed in the process of apposing bone directly on the
particle surface. Marrow spaces were colonized by small
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Table 2: Histomorphometric results of bone biopsies retrieved from sinuses augmented.
MCBA (%) FDBA (%) ABB (%) EB (%) HA-𝛽-TCP 30/70 (%) BC (%)
Newly formed bone 20.1 32.1 16.1 22.8 20.3 21.4
Marrow spaces 57.5 47.8 46.7 47.1 41.8 53.3
Residual graft material 22.4 20.1 37.2 30.1 37.9 25.3
MCBA: mineralized solvent-dehydrated bone
FDBA: freeze-dried mineralized bone allograft
ABB: anorganic bovine bone
EB: equine-derived bone
HA-𝛽-TCP 30/70: synthetic micro-macroporous biphasic calcium-phosphate
BC: Bioapatite-collagen.
and large blood vessels in close proximity to the new
bone and the biomaterial particles. Moderate inflammatory
infiltrate and multinucleated giant cells, probably osteoclasts,
were observed directly on the biomaterial particles surface
(Figure 8(c)). Histomorphometry showed that newly formed
bone represented 21.4 %, marrow spaces 53.3%, and the
residual graft material 25.3%.
The histomorphometric results of bone biopsies are sum-
marized in Table 2.
4. Discussion
Sinus augmentation is a well-documented technique for
creating adequate bone volume to successfully place den-
tal implants in resorbed maxillary posterior regions [36].
However clinical and histological outcomes regarding bone
substitute materials still remain open areas of investigation
because an ideal grafting material should provide biologic
stability, ensure volume maintenance, and induce a high
rate of formation of vital bone and bone remodeling [19].
Although numerous studies have compared grafting materi-
als after sinus augmentation [7, 9, 16, 19, 27, 37–39], no one
has compared histological and histomorphometric results
of MCBA, FDBA, ABB, EB, HA-TCP (30/70), BC, using a
standardized two-stage sinus augmentation model.
Within the limits of the present investigation, whose
results referred to a limited number of patients, the histologi-
cal and histomorphometric analysis of the regenerated tissues
might provide useful information regarding the nature and
amount of newly formed bone of the six tested biomaterials.
At histologic examination all biomaterials were in close
contact with newly formed bone and showed the same
pattern of bone formation surrounding the graft granules
and producing a bridge-like network between the grafted
particles.
From the present histologic investigation, the MCBA
sample showed the highest biocompatibility, because no signs
of acute inflammation were present, which was furthermore
affirmed by the ability to form andmaintain new bone bridg-
ing the greatest part of the biomaterial particles, as reported
by other previous studies [9, 22, 38]. The use of MCBA tends
to result in a slightly lower level of new bone formation
compared to autologous bone, even if this tendency was not
significant in a meta-analysis [3]. At the histomorphometric
examination the percentage of new bone (20.1%) was lower
than the percentage found by Schmitt et al. (35.41%) [8], while
the residual biomaterial (22.4%) was comparable to the value
reported for other graft materials [40]. Moreover, our results
agreedwith histologic examination ofNOUMBISSI et al. [41],
in which the graft turnover (resorption and replacement by
new bone) occurred more rapidly in MCBA.
Histomorphometry of FDBA sample showed that newly
formed bone represented 32.1%, the highest value among the
compared biomaterials. This data was similar to results of
Kolerman et al. [42], who reported 27.5%, but lower than
41.1% described by Cammack et al. [43] and confirmed the
capability to form a larger volume of bone in shorter times
during clinical trials, as reported by other investigations [10,
44]. Sbordone et al. found that FDBA had similar outcomes
compared to autogenous bone in sinus grafting procedure
even when the residual floor thickness was less than 3 mm
[45]. Furthermore, the evidence of resorption phenomena
in our histology confirms that this material could influence
long-term results in regenerated sites [23].
ABB was used as grafting material in a great number of
studies, taking advantage of its well- known osteoconductive
properties [44]. Some authors showed that microvascular
density at 6 months in sinus augmented with ABB was
not significantly different from microvascular density in
sites augmented with autogenous bone [46]. In the present
investigation ABB sample showed areas of new bone forma-
tion in close contact with the biomaterial surface and no
signs of inflammation, suggesting a neutral interaction of
the grafted particles with the new bone tissue. Moreover,
compared to the other biomaterials at the histomorphometric
examination, ABB showed the lowest percentage of newly
formed bone (16.1%) and a higher amount of remaining bio-
material (37.2%). This no homogenous bone structure could,
avoiding bone resorption, guarantee long-term stability of the
augmentedmaxillary sinus [8]. Indeed, Mordenfeld et al. [15]
showed long-term maintenance of these results after 9 years
and Traini et al. [47] after 11 years.
Compared to ABB, EB showed a greater amount of
newly formed bone (22.8%) and lower residual graft material
(30.1%), in accordance with the results of a randomized clini-
cal trial, which evaluated samples harvested 6 months after
sinus augmentation with both of these materials [29]. This
higher resorption could be influenced by a deantigenation
process to which EB is subjected.
The presence, observed in our sample, of new bone
surrounding the biomaterial particles, of many large vessels
and in some fields of osteoblasts apposing bone directly on
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the particle surface is comparable to other studies [27, 47].
The ability of EB to achieve a more rapid and intense vascu-
larization could promote long-term implant osseointegration
and predictability of rehabilitation in regenerated sites.
The HA-𝛽-TCP 30/70 blocks used in the present inves-
tigation had a reticular structure, manufactured by a rapid
prototyping (RP) technique offering a precise control of the
porosity and external shape of a Ha-TCP ratio ceramic bone
substitute [16] so as to influence bone formation.
Indeed, the use of HA-𝛽-TCP 30/70, whose degradation
can be tailored by varying its chemical composition together
with the incorporation of pores, seems to be a good strategy
to overcome the low degradation rate of CaP ceramics, which
represents a limitation of these materials [16].
On 3D reconstruction and quantitative analysis, the
HA/TCP scaffolds exhibited good performances in terms
of both bone regeneration and vascularization, indepen-
dently of the specific scaffold morphology (i.e., granules
or blocks) [47]. However, Giuliani et al. reported that the
scaffold morphology could influence the long-term kinetics
of bone regeneration by showing that block-based specimens
presented better results than granule-based samples [48].
The data of the present study is in agreement with other
investigations concerning bone formation in maxillary sinus
augmentation with HA-beta-TCP (30/70), after a healing
period of 6 months [34, 37].
The histological and histomorphometric aspects of BC
sample were similar to those of the other materials tested and
confirm the osteoconductive property of this biomaterial as
shown in previous studies [34, 35]. Moreover, the plastic and
spongy consistency of this biomaterial renders it very easy
to handle and to shape with scissors, allowing it to be used
in sinus augmentation procedures without any membrane,
in contrast to granular grafts, as suggested by some authors
[49, 50]. Lastly the presence of collagen and glucosamine
improves, respectively, fibrin formation and bonemineraliza-
tion process as confirmed by Maiorana et al. [51, 52].
5. Conclusion
Within the limitations of the present investigation, all the
six biomaterials tested in two-stage maxillary sinus augmen-
tation model showed good biocompatibility and osteocon-
ductive properties and could be used successfully in sinus
augmentation procedure. Although, the FDBA seemed to
have the best histomorphometric result in terms of newly
formed bone and residual graftmaterial. Nevertheless, longer
term histological studies will be needed to understand better
resorption times and modalities [53, 54].
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